Pharmacology · Cytotoxic and Targeted Therapy (Monoclonal Antibodies)

Cyclophosphamide is an alkylating agent that requires hepatic bioactivation. The active metabolite responsible for its cytotoxic and immunosuppressive effect is:

  • A Acrolein
  • B 4-Hydroxycyclophosphamide
  • C Phosphoramide mustard
  • D Aldophosphamide
Correct answer: C. Phosphoramide mustard

Explanation

Cyclophosphamide is hydroxylated by hepatic CYP2B6 (and CYP3A4) to 4-hydroxycyclophosphamide, which spontaneously equilibrates with its ring-open form aldophosphamide. Aldophosphamide undergoes beta-elimination to yield two products: phosphoramide mustard (the active alkylating species that cross-links DNA guanine residues) and acrolein (the toxic byproduct responsible for haemorrhagic cystitis via urothelial damage). Mesna is given to neutralise acrolein. The intermediate metabolites 4-hydroxycyclophosphamide and aldophosphamide are transport forms, not the ultimate alkylating species.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs

See all Cytotoxic and Targeted Therapy (Monoclonal Antibodies) MCQs →